Linked Life Data

20412709

Source:http://linkedlifedata.com/resource/pubmed/id/20412709

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1 Suppl 57
pubmed:dateCreated
2010-4-23
pubmed:abstractText
Abdominal vasculitis represents a rare, but life-threatening manifestation in mixed cryoglobulinemic syndrome (MCsn), despite aggressive immunosuppressive treatments. Anti-CD20 monoclonal antibody, rituximab (RTX) has already been used with good results in MC in preliminary studies. No data have been provided, however, on the efficacy of RTX in gastrointestinal involvement of MCsn. Herein, we report the favourable outcomes of the gastrointestinal manifestations in five patients treated with RTX, where the diagnosis of abdominal vasculitis was confirmed by histopathological findings in 2 out of 5 patients, while in the other three patients the diagnosis was made on the basis of positive endoscopy or by integrating clinical and laboratory data.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
84-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:articleTitle
Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia.
pubmed:affiliation
Rheumatology Clinic, Azienda Ospedaliero Universitaria S. Maria della Misericordia, Udine, Italy.
pubmed:publicationType
Journal Article, Case Reports